LB PHARMACEUTICALS INC
LBRXDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Aug 11, 2026
7dMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
LBRX Earnings Report
EPS Est: $-0.84 | FQ end 2026-06
1 more catalyst beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
LB-102 | Phase 2 | Schizophrenia | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in LB PHARMACEUTICALS INC's drug pipeline?→
CatalystAlert tracks 1 drug candidate in LB PHARMACEUTICALS INC's (LBRX) pipeline across Phase 2. Its lead program is LB-102 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is LB PHARMACEUTICALS INC's next FDA catalyst?→
LB PHARMACEUTICALS INC's (LBRX) next tracked catalyst is a Earnings expected August 11, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track LBRX biotech catalysts?→
Add LBRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow LB PHARMACEUTICALS INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.